Sternbach G, Overton D T
Emergency Services, Stanford University Medical Center, California.
Emerg Med Clin North Am. 1988 May;6(2):341-50.
Percutaneous transluminal coronary angioplasty has shown great promise in the treatment of acute myocardial infarction, both alone and in combination with thrombolysis. Because of time constraints, intravenous thrombolysis probably will emerge as the initial therapy of choice in most settings. Because thrombolysis often has a high incidence of reocclusion and recurrent ischemia, angioplasty will continue to play a role in relieving residual coronary artery stenosis. Coronary artery bypass surgery is not often used currently as sole therapy for acute myocardial infarction. Nonetheless, like angioplasty, bypass surgery plays a supporting role in relieving post-thrombolytic stenosis, as well as in treating complications of angioplasty.
经皮腔内冠状动脉成形术在急性心肌梗死的治疗中已显示出巨大的前景,无论是单独使用还是与溶栓治疗联合使用。由于时间限制,静脉溶栓可能会成为大多数情况下的首选初始治疗方法。由于溶栓后再闭塞和复发性缺血的发生率通常较高,血管成形术将继续在缓解残余冠状动脉狭窄方面发挥作用。冠状动脉搭桥手术目前并不常作为急性心肌梗死的唯一治疗方法。尽管如此,与血管成形术一样,搭桥手术在缓解溶栓后狭窄以及治疗血管成形术并发症方面发挥着辅助作用。